Boxiang Zhang

1.0k total citations
60 papers, 694 citations indexed

About

Boxiang Zhang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Boxiang Zhang has authored 60 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Boxiang Zhang's work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Boxiang Zhang is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Boxiang Zhang collaborates with scholars based in China, United States and Japan. Boxiang Zhang's co-authors include Sida Qin, Xin Sun, Guodong Xiao, Hong Ren, Xiang Li, Chengcheng Yang, Hong Ren, Rui Liang, Chongwen Xu and Yuanyuan Guan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Boxiang Zhang

52 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boxiang Zhang China 17 410 254 145 77 68 60 694
Chuandong Cheng China 13 372 0.9× 228 0.9× 95 0.7× 58 0.8× 51 0.8× 23 604
Xiaodan Hou China 14 484 1.2× 307 1.2× 218 1.5× 48 0.6× 45 0.7× 31 758
Haigang Li China 18 601 1.5× 363 1.4× 171 1.2× 66 0.9× 46 0.7× 42 896
Weixun Chen China 17 387 0.9× 220 0.9× 134 0.9× 100 1.3× 44 0.6× 36 749
Antonio Martínez‐Torteya Mexico 10 445 1.1× 202 0.8× 171 1.2× 163 2.1× 25 0.4× 32 827
Zai Luo China 14 582 1.4× 442 1.7× 86 0.6× 149 1.9× 46 0.7× 51 979
Giu‐Cheng Hsu Taiwan 19 423 1.0× 269 1.1× 267 1.8× 58 0.8× 115 1.7× 43 980
Binhui Xie China 12 382 0.9× 275 1.1× 79 0.5× 60 0.8× 29 0.4× 27 747
Yunfei He China 17 411 1.0× 212 0.8× 145 1.0× 58 0.8× 36 0.5× 41 788

Countries citing papers authored by Boxiang Zhang

Since Specialization
Citations

This map shows the geographic impact of Boxiang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boxiang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boxiang Zhang more than expected).

Fields of papers citing papers by Boxiang Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boxiang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boxiang Zhang. The network helps show where Boxiang Zhang may publish in the future.

Co-authorship network of co-authors of Boxiang Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Boxiang Zhang. A scholar is included among the top collaborators of Boxiang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boxiang Zhang. Boxiang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ma, Jiao, Fengyi Zhao, Tao Wu, et al.. (2025). IINS Vs CALLY Index: A Battle of Prognostic Value in NSCLC Patients Following Surgery. Journal of Inflammation Research. Volume 18. 493–503. 1 indexed citations
3.
Zhang, Boxiang, et al.. (2025). Bibliometric analysis of immune-related acute kidney injury induced by cancer immunotherapy (2000–2025). Naunyn-Schmiedeberg s Archives of Pharmacology. 399(2). 2647–2662. 1 indexed citations
4.
Zhang, Fan, et al.. (2024). The Role of Marein During Endothelial-Mesenchymal Transition in Diabetic Kidney Disease. International Journal of Morphology. 42(4). 1080–1095.
5.
Che, Shaomin, Nanzheng Chen, Junke Fu, et al.. (2024). Tislelizumab combined with chemotherapy or radiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (TINES): A randomized, open, phase II study.. Journal of Clinical Oncology. 42(16_suppl). e16090–e16090.
6.
Wu, Jie, Ting Wen, Antonio Marzio, et al.. (2024). FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression. Cell Death and Disease. 15(4). 282–282. 9 indexed citations
7.
Chen, Xiyao, Boxiang Zhang, Yeqiong Zhang, et al.. (2024). Serum sPD‐1 and sPDL1 as predictive biomarkers for HBsAg clearance in HBeAg‐negative CHB patients undergoing IFN‐based therapy. Alimentary Pharmacology & Therapeutics. 60(5). 593–603. 1 indexed citations
8.
9.
Zhang, Boxiang, Yonggen Ling, Yuanyuan Guan, et al.. (2023). ShuffleTrans: Patch-wise weight shuffle for transparent object segmentation. Neural Networks. 167. 199–212. 7 indexed citations
10.
Song, Dingli, et al.. (2023). Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma. Cancer Cell International. 23(1). 322–322. 3 indexed citations
11.
Du, Ning, et al.. (2023). Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage. Canadian Respiratory Journal. 2023. 1–12. 4 indexed citations
12.
Zhang, Boxiang, et al.. (2023). Mx2M: Masked Cross-Modality Modeling in Domain Adaptation for 3D Semantic Segmentation. Proceedings of the AAAI Conference on Artificial Intelligence. 37(3). 3401–3409. 4 indexed citations
13.
Liu, Suping, et al.. (2023). Development of the prognostic value in lung adenocarcinoma based on anoikis‐related genes and initial experimental validation. The Journal of Gene Medicine. 25(9). e3534–e3534. 3 indexed citations
15.
Yang, Chengcheng, Dingli Song, Jie Wu, et al.. (2022). Comprehensive analysis of the prognostic value and immune infiltration of FGFR family members in gastric cancer. Frontiers in Oncology. 12. 936952–936952. 10 indexed citations
16.
Fu, Junke, Ziwei Wang, Nanzheng Chen, et al.. (2022). The role of magnetic anchoring and traction technique in thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve. Surgical Endoscopy. 36(5). 3653–3662. 4 indexed citations
17.
Zhang, Jing, et al.. (2022). TAF1 promotes NSCLC cell epithelial-mesenchymal transition by transcriptionally activating TGFβ1. Biochemical and Biophysical Research Communications. 636(Pt 2). 113–118. 6 indexed citations
18.
Zhang, Boxiang, Rui Wang, Kai Li, et al.. (2021). An Immune-Related lncRNA Expression Profile to Improve Prognosis Prediction for Lung Adenocarcinoma: From Bioinformatics to Clinical Word. Frontiers in Oncology. 11. 671341–671341. 10 indexed citations
19.
Zhang, Boxiang, Chengcheng Yang, Rui Wang, et al.. (2020). OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3. Journal of Experimental & Clinical Cancer Research. 39(1). 244–244. 30 indexed citations
20.
Qin, Sida, Chengcheng Yang, Xifang Wang, et al.. (2012). Overexpression of Smac Promotes Cisplatin-Induced Apoptosis by Activating Caspase-3 and Caspase-9 in Lung Cancer A549 Cells. Cancer Biotherapy and Radiopharmaceuticals. 28(2). 177–182. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026